Open channel block and alteration of N-methyl-D-aspartic acid receptor gating by an analog of phencyclidine.
J G Dilmore, J W Johnson
Biophysical Journal October 1998 DOI: 10.1016/s0006-3495(98)77622-2 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | In vitro electrophysiology study Peer reviewed |
|---|---|
| Intervention | NEFA |
| Key points | NEFA inhibits NMDA receptor responses with an IC50 of 0.51 microM at -66 mV by binding to the open channel and being trapped when the channel closes. Single-channel recordings show it reduces mean open time with a forward blocking rate of 39.9 microM-1 s-1. The authors conclude that PCP-like blockers modify channel gating in addition to blocking current flow through the open channel. |
Abstract
We investigated inhibition of the N-methyl-D-aspartic acid (NMDA) receptor-channel complex by N-ethyl-1,4,9, 9alpha-tetrahydro-4alphaR-cis-4alphaH-fluoren-++ +4alpha-amine (NEFA), a structural analog of phencyclidine (PCP). Using the whole-cell recording technique, we demonstrated that NEFA inhibits NMDA responses with an IC50 of 0.51 microM at -66 mV. We determined that NEFA binds to the open channel, and subsequently the channel can close and trap the blocker. Once the channel has closed, NEFA is unable to dissociate until the channel reopens. Single-channel recordings revealed that NEFA reduces the mean open time of single NMDA-activated channels in a concentration-dependent manner with a forward blocking rate (k+) of 39.9 microM-1 s-1. A computational model of antagonism by NEFA was developed and constrained using kinetic measurements of single-channel data. By multiple criteria, only models in which blocker binding in the channel causes a change in receptor operation adequately fit or predicted whole-cell data. By comparing model predictions and experimental measurements of NEFA action at a high NMDA concentration, we determined that NEFA affects receptor operation through an influence on channel gating. We conclude that inhibition of NMDA receptors by PCP-like blockers involves a modification of channel gating as well as block of current flow through the open channel.
Citations in the library
Cited by 4
- Historical Pathways for Opioid Addiction, Withdrawal with Traditional and Alternative Treatment Options with Ketamine, Cannabinoids, and Noribogaine: A Narrative Review Health Psychology Research October 6, 2022
- Application and assessment of deep learning for the generation of potential NMDA receptor antagonists. Physical chemistry chemical physics : PCCP January 21, 2021
- Hydroxynorketamine Blocks N-Methyl-d-Aspartate Receptor Currents by Binding to Closed Receptors Molecular Pharmacology June 29, 2020
- The role of the hippocampo-prefrontal cortex system in phencyclidine-induced psychosis: a model for schizophrenia. Journal of physiology, Paris December 1, 2013
Cites 4
- Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans Archives of General Psychiatry March 1, 1994
- Study of a New Schizophrenomimetic Drug—Sernyl Archives of Neurology And Psychiatry March 1, 1959
- The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Brain research. Brain research reviews February 1, 1995
- Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones. The Journal of Physiology January 1991